hVIVO (HVO) Competitors GBX 9.98 -0.23 (-2.21%) As of 08:18 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. FARN, VRP, ARIX, BVXP, CIR, 4BB, AVCT, TILS, VSN, and OBIShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), Circassia Group (CIR), 4basebio (4BB), Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), and Ondine Biomedical (OBI). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Arix Bioscience Bioventix Circassia Group 4basebio Avacta Group Tiziana Life Sciences Verseon Ondine Biomedical hVIVO (LON:HVO) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership. Do analysts recommend HVO or FARN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Faron Pharmaceuticals Oy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in HVO or FARN? 34.9% of hVIVO shares are held by institutional investors. Comparatively, 10.7% of Faron Pharmaceuticals Oy shares are held by institutional investors. 14.0% of hVIVO shares are held by company insiders. Comparatively, 31.8% of Faron Pharmaceuticals Oy shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, HVO or FARN? hVIVO has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Is HVO or FARN more profitable? hVIVO has a net margin of 25.96% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. hVIVO's return on equity of 47.93% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% Faron Pharmaceuticals Oy N/A 0.46%-70.00% Does the media refer more to HVO or FARN? In the previous week, hVIVO had 1 more articles in the media than Faron Pharmaceuticals Oy. MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy's average media sentiment score of 1.04 beat hVIVO's score of 0.59 indicating that Faron Pharmaceuticals Oy is being referred to more favorably in the news media. Company Overall Sentiment hVIVO Positive Faron Pharmaceuticals Oy Positive Which has stronger valuation & earnings, HVO or FARN? hVIVO has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£68.74M1.03£17.84M£2.424.11Faron Pharmaceuticals OyN/AN/A-£60.23M-£37.39-5.35 SummaryhVIVO beats Faron Pharmaceuticals Oy on 12 of the 14 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£70.58M£130.76M£5.52B£3.00BDividend Yield1.10%3.74%4.25%5.02%P/E Ratio4.113.6027.95164.09Price / Sales1.034,343.88438.79283,944.96Price / Cash4.9413.1935.5327.97Price / Book1.7942.238.254.62Net Income£17.84M-£92.15M£3.23B£5.90B7 Day Performance-2.21%0.05%-0.13%2.12%1 Month Performance-5.00%4.25%7.21%8.54%1 Year Performance-65.90%164.99%27.45%64.39% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVON/AGBX 9.98-2.2%N/A-63.2%£70.58M£68.74M4.11N/AFARNFaron Pharmaceuticals OyN/AGBX 202.50-2.4%N/A+52.3%£271.86MN/A-5.4234Positive NewsVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919BVXPBioventixN/AGBX 2,738+0.5%N/A-33.9%£143.37M£13.65M17.7112Gap DownCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down4BB4basebio1.6906 of 5 starsGBX 1,000flatGBX 1,600+60.0%-34.0%£128.10M£311K-1,282.05101Gap UpHigh Trading VolumeAVCTAvacta GroupN/AGBX 32.60+1.9%N/A-53.1%£123.84M£26.29M-4.20120TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpOBIOndine BiomedicalN/AC$14.11-2.7%N/A+75.0%C$101.45MC$48.60K-4.25N/AGap Down Related Companies and Tools Related Companies FARN Competitors VRP Competitors ARIX Competitors BVXP Competitors CIR Competitors 4BB Competitors AVCT Competitors TILS Competitors VSN Competitors OBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
